We have located links that may give you full text access.
The intraocular pressure could not be used to determine the intracranial pressure in patients with hydrocephalus.
International Journal of Neuroscience 2018 June 9
PURPOSE: An accurate intracranial pressure (ICP) measurement is vital for patients with hydrocephalus. ICP is generally measured by lumbar puncture opening pressure, which is invasive and has potential adverse side effects. Intraocular pressure (IOP) was investigated to measure ICP indirectly; however, its accuracy was controversial. We conducted this retrospective study to investigate whether IOP can be used as a surrogate for ICP in hydrocephalus patients.
METHODS: We performed a retrospective study enrolled 50 cases, including 32 patients with normal pressure hydrocephalus (NPH) and 18 patients with high pressure hydrocephalus (HPH). The independent factors of ICP, the correlation between ICP and other factors, and diagnostic value of IOP and papilledema to predict ICP were analysed respectively.
RESULTS: Patients with HPH were more likely suffered from visual deterioration (33.33% vs. 9.38%, p = 0.045) and papilledema (55.56% vs. 3.13%, p = 0.001). Multivariate analysis revealed that papilledema was a significant factor (OR = 40.765, 95% CI 3.331-498.846, p = 0.004). Pearson correlation analysis indicated that ICP did not correlate with any other factors.
CONCLUSIONS: IOP was not an independent factor of ICP in patients with hydrocephalus, and could not be used to determine IOP. Papilledema might be a significant factor of ICP in hydrocephalus sufferers. Compared with NPH patients, patients with HPH were more prone to develop papilledema.
METHODS: We performed a retrospective study enrolled 50 cases, including 32 patients with normal pressure hydrocephalus (NPH) and 18 patients with high pressure hydrocephalus (HPH). The independent factors of ICP, the correlation between ICP and other factors, and diagnostic value of IOP and papilledema to predict ICP were analysed respectively.
RESULTS: Patients with HPH were more likely suffered from visual deterioration (33.33% vs. 9.38%, p = 0.045) and papilledema (55.56% vs. 3.13%, p = 0.001). Multivariate analysis revealed that papilledema was a significant factor (OR = 40.765, 95% CI 3.331-498.846, p = 0.004). Pearson correlation analysis indicated that ICP did not correlate with any other factors.
CONCLUSIONS: IOP was not an independent factor of ICP in patients with hydrocephalus, and could not be used to determine IOP. Papilledema might be a significant factor of ICP in hydrocephalus sufferers. Compared with NPH patients, patients with HPH were more prone to develop papilledema.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app